Innovation Pharmaceuticals Inc. (IPIX)
OTCMKTS: IPIX · Delayed Price · USD
0.0003
0.00 (0.00%)
Aug 30, 2024, 4:00 PM EDT - Market closed
IPIX Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
158.78K
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 385.44B |
Johnson & Johnson | 86.58B |
Merck & Co. | 62.48B |
AbbVie | 55.00B |
AstraZeneca | 49.13B |
Novartis AG | 48.86B |
Thermo Fisher | 42.35B |
Abbott Laboratories | 40.73B |
IPIX News
- 1 year ago - Innovation Pharmaceuticals Announces New Milestone at BeaMed; On Track to File 510(k) Submission to FDA in Q2 2024 - GlobeNewsWire
- 1 year ago - Innovation Pharmaceuticals Provides Update on U.S. Patent Applications Covering Use of Brilacidin in Inflammatory Bowel Diseases, Coronaviruses and Fungal Diseases - GlobeNewsWire
- 1 year ago - Innovation Pharma Announces BeaMed Technologies Breakthrough in Development of Fiber Optic Probes for StingRay Laser System; Paves Way for Groundbreaking Integration Testing - GlobeNewsWire
- 1 year ago - Innovation Pharmaceuticals Brilacidin Antifungal Research Published in Nature Communications - GlobeNewsWire
- 1 year ago - Innovation Pharmaceuticals Announces New Antifungal Testing of Brilacidin by NIH/NIAID-Affiliated and Other Academic Researchers - GlobeNewsWire
- 1 year ago - Innovation Pharmaceuticals Visits BeaMed; New StingRay Laser System for Epilepsy and Brain Tumors Moving Toward FDA Submission - GlobeNewsWire
- 1 year ago - Innovation Pharmaceuticals Announces BT BeaMedical Technologies and Shina Systems Ltd. Enter into a Definitive Strategic Development Agreement - GlobeNewsWire
- 1 year ago - Innovation Pharmaceuticals Reports New In Vivo Antifungal Data Showing Brilacidin's Potential for Treating Fungal Keratitis - GlobeNewsWire